HK Stock MarketDetailed Quotes

09995 REMEGEN

Watchlist

14.660
-0.340-2.27%

Trading Oct 17 13:01 CST

7.98BMarket Cap-4585P/E (TTM)

REMEGEN Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

REMEGEN Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q2	409.221M / 376.000M	--
Mar 27, 2024	2023/Q4	306.660M / 361.000M	--
Mar 29, 2023	2022/Q4	198.139M / 206.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q2409.221M / 376.000M--

Mar 27, 20242023/Q4306.660M / 361.000M--

Mar 29, 20232022/Q4198.139M / 206.000M--

--------

Unlock Free Earnings Estimates

Open Account

REMEGEN Earnings Reports

REMEGEN: 2024 Interim Report

Sep 25 04:47 ET

榮昌生物：有關2023年年報的補充公告

Aug 26 10:23 ET

REMEGEN: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024

Aug 16 08:10 ET

REMEGEN: DATE OF BOARD MEETING

Aug 6 04:33 ET

Analyst Rating

Updated: Oct 17, 2024

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall